Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713916 · ClinicalTrials.gov registry record · NA
Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 648
- Enrollment target
NCT05713916: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05713916 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 648 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05713916, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 648 participants
- Enrollment target
Study Summary
The electronic health record contains vast amounts of cardiovascular data, including potential clues that an individual may have unrecognized cardiac conditions. One important example is the finding of thickened heart muscle -- known as left ventricular hypertrophy (LVH) -- on echocardiograms (heart ultrasounds). If the underlying cause of LVH is untreated, individuals are at an increased risk of developing more severe pathology. As the most common cause of LVH, hypertension and its downstream consequences account for more cardiovascular deaths than any other modifiable risk factor. Critically, many individuals have signs of cardiac damage from hypertension before it is diagnosed or treated. Despite this evidence, there are often gaps in healthcare delivery that contribute to substandard recognition and treatment. Thus, there is an urgent need to validate alternative cost-effective screening and intervention strategies. Echocardiograms are ordered by many specialties and for numerous indications. Even when LVH is reported, the finding may be underappreciated and not prompt further evaluation. Whether data from prior echocardiograms can be harnessed to improve patient care through a centralized intervention is unknown. Accordingly, the goal of this randomized pragmatic clinical trial is to study the impact of a centralized clinical support pathway on the diagnosis and treatment of hypertension and the recognition of LVH-associated diseases in individuals with evidence of thickened heart muscle on previously performed echocardiograms.
Interventions
- OTHER Intervention: Population Health Coordinator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 648 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05713916
The ClinicalTrials.gov registry entry for NCT05713916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 648 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intervention: Population Health Coordinator is the first listed.
NCT05713916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05713916 about?
NCT05713916 is a clinical study titled "Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy". The electronic health record contains vast amounts of cardiovascular data, including potential clues that an individual may have unrecognized cardiac conditions. One important example is the finding of thickened heart muscle -- known as left ventricular hypertrophy (LVH) -- on echocardiograms (heart...
What is the current status of trial NCT05713916?
This trial is currently completed. It is a NA study. The enrollment target is 648 participants. The study started on 2023-03-20. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT05713916?
The interventions under investigation include: Intervention: Population Health Coordinator (OTHER).
Who is sponsoring clinical trial NCT05713916?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.